Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicates recruitment for a kisspeptin-based approach to quantify GnRH neuronal function across health and disease, including repr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kisspeptin-54 (Kisspeptin-54)

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Reproductive Disorder, Neurodegeneration | Phase 1 | Status: RECRUITING